ESSENTIAL AAV & LVV

Scalable Vector for Speed to Clinic

 

Essential AVV-LVV Website Header (1)

DELIVERING YOUR GMP BATCH OF VECTOR IN UNDER 12 MONTHS

When it comes to obtaining your GMP batch of AAV or LVV vector for your advanced therapy, it’s critical to consider the scalability of your process for your long-term success. If your AAV or LVV vector manufacturing partner lacks the infrastructure to guide you past a Phase I trial, you may have to switch providers midstream, piling up additional costs and delays.  

It’s time for a more viable alternative to accelerate your advanced therapy right from the start. 

MEET ESSENTIAL: A SCALABLE VECTOR OFFERING FOR AVV & LVV

With the Essential vector offering from Resilience, you can secure a 200L batch of GMP AAV or LVV vector in under 12 months using our scalable platform. As your program evolves and your scale increases, we’ll work with you to meet patient & commercial demands thanks to the consistency of the bioreactor platform used from one scale to the next. 

With the Essential vector manufacturing offering, you’ll lean on the knowledge and experience of our expert team to take your program to the next level without needing de novo process development work. Essential leverages the same bioreactor platform to minimize any manipulations to your process as you successfully scale up your GMP vector batch to up to 200L of AAV or LVV.

  

Resilience_1400

ESSENTIAL FOR AAV

ESSENTIAL FOR LVV

  • 50L or 200L of GMP AAV product released in less than 12 months when all raw materials are available up front
  • Quality reviewed reports including CoA
  • Path to commercialization
  • 200L of GMP LVV product released in less than 12 months when all raw materials are available up front
  • Quality reviewed reports including CoA
  • Path to commercialization
Essential AVV-LVV Timeline

Capitalize on streamlined processes optimized for AAV and LVV manufacturing through a plug-and-play approach

Prepare for the future by leveraging our team’s understanding of key operational and regulatory considerations 

Maintain continuity through the same cell line and analytics in scaling late-phase/commercial processes 

The timeline assumes all raw materials are available up front. Not every project is an ideal candidate for the Essential offering, especially when your innovation would benefit from a custom development program or if you require a smaller batch size. If this sounds like you, reach out and we can discuss additional options.
LET'S TALK VECTORS. AND YOUR SUCCESS

Is your current program a good fit for Essential?  Let’s connect and talk more about what’s driving your needs, objectives, and project dynamics.

NATIONAL RESILIENCE